Decipher Biosciences is a California-based biotechnology company that develops and commercializes genomic assays for the treatment of urologic cancer.
Business Model:
Revenue: $40M
Employees: 51-200
Decipher Biosciences was acquired by
Veracyte.
The acquisition happend on 2021-02-03.
Details of the transaction were not public
Address: 6925 Lusk Boulevard
City: San Diego
State: CA
Zip: 92121
Country: US
Decipher Biosciences is a California-based biotechnology company that develops and commercializes genomic assays for the treatment of urologic cancer.
Contact Phone:
+18887921601
Contact Email:
Listed Exchange:
NASDAQ
Ticker Symbol:
DECI
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2020 | Equity | $8M |
Capital Royalty Group, LLC Novartis Venture Funds |
7/2018 | Equity | $2.7M |
CRG,LP Tekla Capital Management |
12/2018 | Debt | $3.2M |
Capital Royalty Group, LLC Novartis Venture Funds |
7/2017 | Series C | 1 | - |
Yonjin Venture Yonjin Venture |
10/2018 | Equity | $3.4M |
Tekla Capital Management |
3/2019 | Venture Round | $13M | 7/2017 | Series C | 1 | - |
Yonjin Venture Yonjin Venture |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|